KIF11 and neoplasm: Aberrant upregulation of kinesin family members could lead to uncontrolled tumor growth, and hence mitotic kinesin inhibitors such as KIF11-targeted inhibitors and CENPE-targeted inhibitors have attracted great attention in drug development 6.